Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Pharma-Bio Serv (PBSV) Loans and Notes Receivables (2018 - 2020)

Pharma-Bio Serv filings provide 3 years of Loans and Notes Receivables readings, the most recent being $1.2 million for Q4 2020.

  • On a quarterly basis, Loans and Notes Receivables changed 0.0% to $1.2 million in Q4 2020 year-over-year; TTM through Oct 2020 was $1.2 million, a 0.0% change, with the full-year FY2020 number at $1.2 million, changed 0.0% from a year prior.
  • Loans and Notes Receivables hit $1.2 million in Q4 2020 for Pharma-Bio Serv, roughly flat from $1.2 million in the prior quarter.
  • In the past five years, Loans and Notes Receivables ranged from a high of $1.8 million in Q4 2018 to a low of $1.2 million in Q4 2019.
  • Median Loans and Notes Receivables over the past 3 years was $1.2 million (2019), compared with a mean of $1.4 million.
  • Biggest five-year swings in Loans and Notes Receivables: fell 28.57% in 2019 and later changed 0.0% in 2020.
  • Pharma-Bio Serv's Loans and Notes Receivables stood at $1.8 million in 2018, then fell by 28.57% to $1.2 million in 2019, then changed by 0.0% to $1.2 million in 2020.
  • The last three reported values for Loans and Notes Receivables were $1.2 million (Q4 2020), $1.2 million (Q4 2019), and $1.8 million (Q4 2018) per Business Quant data.